Belite Bio, Inc, ADR (BLTE) PT Raised to $266 at Cantor Fitzgerald After Higher WAC Announced
Tweet Send to a Friend
Cantor Fitzgerald analyst Steve Seedhouse raised the price target on Belite Bio, Inc, ADR (NASDAQ: BLTE) to $266.00 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
